Asahi Kasei Pharma Corporation. Asahi KASEI
Asahi Kasei Pharma Corporation has been producing natural-type coenzyme Q10 by fermentation in accordance with the standards for manufacture of medicines (GMP) for more than 25 years and supplying it around the world.We have adopted various safety measures, such as avoiding the use of recombinant microorganisms for fermentation and using no raw materials of animal origin in any of the manufacturing processes.
Naturally the best !
Home Top pages for professionals Quality assurance system Responsible Care Stability of CoQ10 Safety of CoQ10
HOME > Top pages for professionals > Safety of Coenzyme Q10
Safety of Coenzyme Q10
Single-Dose Toxicity
Mice1) : Maximum 5000 mg/kg in a single oral administration
No cases of animal death were reported.
Repeated-Dose Toxicity
Rats1): Maximum 1200 mg/kg  13-week oral administration
Rats2): Maximum 1000 mg/kg  5-week oral administration
Rats2): Maximum 600 mg/kg  26-week oral administration
Rabbits3): Maximum 600 mg/kg  23-day oral administration
No abnormalities were reported with regard to body weight, general condition, blood and biochemical findings, necropsy, or histopathology.
Mutagenicity Test 1)
Chromosome Aberration Test:  Chinese hamster lung fibroblast (CHL/IU) cells
Neither structural chromosomal aberrations nor numerical chromosomal aberrations were induced.
Ames Test: One strain of E. coli and four strains of Salmonella typhimurium
No reverse mutagenic activity was observed in any of the strains.
Teratogenicity Test 4)
Primigravid rats and mice:  600 mg/kg/day, orally administered for 7 consecutive days during fetal organogenesis
No fatalities, growth suppression, or teratogenicity to embryos, nor influence on form or functional differentiation of newborns was observed.
Irritation Test (Skin and Eyes) 1)
Primary Skin Irritation Test (rabbits):  Ten mg/mL or 1 mg/mL was applied to normal skin and broken skin of male rabbits for 24 hrs.
No skin irritation reaction was observed on any of the treated areas.
Accumulated Skin Irritation Test (rabbits):  A 0.1% solution was applied repeatedly eleven times to normal skin and broken skin of five rabbits.
No skin irritation reaction was observed on any of the treated areas.
Primary Ocular Irritation Test (rabbits):   Ten mg/mL or 1 mg/mL was applied to the conjunctival sacs of rabbit eyes.
No primary ocular irritation was observed.
Photo-irritation Test (guinea pigs):  Five w/v% solution was applied to the skin, which was subsequently exposed to ultraviolet radiation.
No skin reaction was observed on any of the treated areas 24, 48 or 72 hours after exposure to ultraviolet radiation.
Sensitization Test 1)
Skin Sensitization Test (guinea pigs):  Up to a maximum 2.5 w/v% solution was applied to the skin after an endermic injection of a 10 w/v% suspension, and then a 10 w/v% solution was applied to the skin.
No skin reaction was observed on any of the treated areas 24, 48 or 72 hours after application.
Photo Sensitization Test (guinea pigs):  Ten w/v% solution was applied to the skin, and then up to a maximum 2.5 w/v% solution was applied to the skin, which was exposed to ultraviolet radiation.
No skin reaction was observed on any of the treated areas.
1) In-house data, Asahi Kasei Pharma Corporation
2) Chiba T, et al., Oyo Yakuri, 6 (4), 769-779 (1972)
3) Chiba T, et al., Oyo Yakuri, 6 (4), 781-786 (1972)
4) Notake Y, et al., Iyakuhin Kenkyu, 3 (3), 306-315 (1972)
Privacy Policy
Copyrit (c) Asahi Kasei Pharma Corporation. All rights reserved.